Prevalence of the XXXX in hemodialysis.

@entity1 @entity1674 @entity281 @entity65 @entity209 @entity413
BACKGROUND: Recently, the concept of the @entity209 ( @entity209 ) has emerged in an effort to group and study as a whole several cardiovascular risk factors. The @entity209 requires the presence of 3 or more of the following parameters: high blood pressure (>/= 130/85), waist circumference >102 cm in @entity1 and >88 cm in @entity1 , HDL<50 mg/dL in @entity1 and <40 mg/dL in women, serum @entity1674 >150 mg/dL and fasting blood @entity413 >/= 110 mg/dL. OBJECTIVES: To investigate the prevalence of the @entity209 and the specific @entity1 characteristics in a cohort of hemodialysis @entity1 . MATERIALS AND METHODS: 102 stable @entity1 on maintenance hemodialysis (63 male/39 female with a mean time on dialysis of 57.19 +/- 47.16 months) were studied for 12 months. RESULTS: The prevalence of the @entity209 is high (56.25%) during the first year on dialysis and gradually declines (44.8% from 2-5 years and 29.7% for >5 years). In total 41/102 @entity1 had @entity209 (40.19%); 28/41 were @entity1 (68.29%) and 13/41 @entity1 (31.7%). The prevalence of @entity209 in males was 44.4% (28/63) and 33.3% (13/39) in females, while the most frequent combination of risk factors in @entity209 @entity1 was high blood pressure-high waist circumference-high levels of serum @entity1674 (36.58%). Serum @entity1674 >150 mg/dL is the most frequent component of the @entity209 both in well-nourished @entity1 and according to the duration of dialysis (58.53% for 0-5 years and 19.51% for >5 years on dialysis). @entity209 @entity1 had a better nutritional status and were on dialysis for less time than their @entity209 ( @entity209 ) counterparts. Actual or anamnestic cardiovascular events and @entity281 did not differ between the 2 groups. CONCLUSIONS: Our study provides new data concerning the prevalence of the @entity209 and the specific @entity1 characteristics in a hemodialysis population. The prevalence of @entity209 in hemodialysis @entity1 is high (40.19%) and seems to reflect a state of good nutrition compared to @entity1 without the @entity209 . Furthermore, the @entity209 is more common in the first years of dialysis (42.46+/-34.29 months) than later on (67.25+/-52.15 months) probably reflecting the long term consequences of the hemodialysis treatment. Our results also indicate that although @entity1 in the @entity209 group were well-nourished and for a shorter time on dialysis, they were not protected from @entity65 and @entity281 . Our study provides new data concerning both the prevalence of the @entity209 and a variety of @entity1 characteristics in a hemodialysis population. Further research and a larger number of @entity1 are required in order to clarify the precise role of this syndrome in @entity1 on MHD.
